Rapid Micro Biosystems, Inc. reaffirmed revenue guidance for the fiscal year 2023. for the year, the company expects its total revenue guidance of at least $22.0 million, representing growth of approximately 30% compared to full year 2022, and the placement of at least 15 systems.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | -2.44% | -2.44% | +8.11% |
May. 03 | Transcript : Rapid Micro Biosystems, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
May. 03 | Earnings Flash (RPID) RAPID MICRO BIOSYSTEMS Posts Q1 Revenue $5.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.11% | 34.29M | |
+40.73% | 739B | |
+31.76% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.77% | 240B | |
+9.53% | 210B | |
-4.87% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- RPID Stock
- News Rapid Micro Biosystems, Inc.
- Rapid Micro Biosystems, Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023